GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Gross-Profit-to-Asset %
中文

Biosyntech (Biosyntech) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2009)


View and export this data going back to 2000. Start your Free Trial

What is Biosyntech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Biosyntech's annualized Gross Profit for the quarter that ended in Dec. 2009 was $0.00 Mil. Biosyntech's average Total Assets over the quarter that ended in Dec. 2009 was $4.87 Mil. Therefore, Biosyntech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2009 was 0.00%.


Biosyntech Gross-Profit-to-Asset % Historical Data

The historical data trend for Biosyntech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Gross-Profit-to-Asset % Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.80 0.42 0.99 1.71 0.34

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.72 2.25 6.50 -

Competitive Comparison of Biosyntech's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Biosyntech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Biosyntech's Gross-Profit-to-Asset % falls into.



Biosyntech Gross-Profit-to-Asset % Calculation

Biosyntech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2009 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2009 )/( (Total Assets (A: Mar. 2008 )+Total Assets (A: Mar. 2009 ))/ count )
=0.02/( (6.098+5.693)/ 2 )
=0.02/5.8955
=0.34 %

Biosyntech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2009 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2009 )/( (Total Assets (Q: Sep. 2009 )+Total Assets (Q: Dec. 2009 ))/ count )
=0/( (4.716+5.015)/ 2 )
=0/4.8655
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2009) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Biosyntech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Biosyntech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyntech (Biosyntech) Business Description

Traded in Other Exchanges
N/A
Address
475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines